openPR Logo
Press release

Asparaginase Market is Driven by Rapid Growth in the Pharmaceutical and Food Industry

01-12-2018 07:12 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
Asparaginase Market is Driven by Rapid Growth in

Global Asparaginase Market: Overview

Asparaginase also known as crisantaspase, is an enzyme used in food and pharmaceutical manufacturing. It is one of the medicine in the World Health Organization's List of Essential Medicines, made from bacterial species such as Erwinia chrysanthemi and Escherichia coli. Asparaginase is used in the food manufacturing to reduce the formation of acrylamide.

Acrylamide is a carcinogen in the starch containing food products such as biscuits and snacks. In pharmaceuticals, Asparaginase is used to treat various diseases and disorders such as non-Hodgkin's lymphoma, acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL). The North America Asparaginase market accounts for relatively high revenue share, followed by Western Europe Asparaginase market. Whereas, APEJ account for relatively high volume share in global Asparaginase market with significant growth rate.

Download PDF Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=24116

Global Asparaginase Market: Dynamics

Some of the important factor fuelling the growth of global Asparaginase market include growing pharmaceutical and food industry. To counter the same, Asparaginase market players are investing in research and development and production of Asparaginase to meet the regulatory specification with increasing demand. Some macroeconomic factors making a positive impact on global Asparaginase market includes increasing population, the rapid rate of urbanization, and growing domestic income. Major restraining factors for global Asparaginase market are its side effect in human body pancreatitis, mild Bone marrow suppression, anticoagulant factor resulting in the stroke and bleeding, decreases protein synthesis and hypersensitivity or allergic reaction. The trend identified in the global Asparaginase market is mergers and acquisitions between Asparaginase producers and finished product manufacturers such as pharmaceuticals and food. The company manufacturing Asparaginase products has a significant opportunity in regions such as North America, Europe, and Asia Pacific, attributed to high demand for pharmaceuticals across the regions. Companies have a significant opportunity in global Asparaginase market through collaboration with end-users i.e. food and pharmaceutical manufacturers.

Global Asparaginase Market: Segmentation

The global Asparaginase market is segmented by end-use and by region. By end-use, the global Asparaginase market is fragmented as healthcare Industry and food industry. Among these, the healthcare Industry segment is expected to contribute to the significant revenue share with a relatively high growth rate over the forecast period in the global Asparaginase market followed by food industry segment with a relatively high growth rate considering both value and volume in the global Asparaginase market.

Global Asparaginase Market: Regional Overview

By geographies, the global Asparaginase market is segmented into seven regions -- North America, Western Europe, Asia-Pacific except Japan (APEJ), Eastern Europe, Latin America, the Middle East & Africa, and Japan. Among the regions, North America dominates the global Asparaginase market in terms of value, owing to a significant revenue share of the region in the pharmaceutical industry. Western Europe is followed by North America in the global Asparaginase market, attributed to rapidly rising demand for food and beverages across the region. Eastern Europe and Japan also accounts for significant value share in the global Asparaginase market. The APEJ is expected to account for relatively high volume share in the global Asparaginase market, owing to a relatively high growth rate of pharmaceutical and food industry across the globe. Latin America and Middle East Africa is expected to have relatively high opportunity for Asparaginase market players, attributed to high growth rate of the healthcare sector in the regions. Overall, the outlook for the global Asparaginase market will have a positive growth over the forecast period.

Obtain Report Details @ https://www.transparencymarketresearch.com/asparaginase-market.html

Global Asparaginase Market: Key Players

Few players of Asparaginase market include Novus Biologicals, Taj Pharmaceuticals Limited, Porton Biopharma, Xiamen Hisunny Chemical Co., Ltd., Jinan Haohua Industry Co., Ltd., Simagchem Corporation, LGM Pharma, Leap Labchem Co., Ltd., Hangzhou J&H Chemical Co., Ltd., Hangzhou Dayangchem Co. Ltd., Gihi Chemicals Co., Limited, Chemos GmbH & Co. KG

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Transparency Market Research
90 State Street, Suite 700,
Albany, NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Asparaginase Market is Driven by Rapid Growth in the Pharmaceutical and Food Industry here

News-ID: 896941 • Views:

More Releases from Transparency Market Research

Handheld Marijuana Vaporizer Market Key Drivers, Market Research, and Insights for the USD 15.9 Bn Market 2022-2031
Handheld Marijuana Vaporizer Market Key Drivers, Market Research, and Insights f …
The global handheld marijuana vaporizer market has witnessed remarkable growth in recent years, attributed to the increasing acceptance of medicinal marijuana and the demand for convenient and discreet consumption methods. Valued at US$ 5 billion in 2021, the market is projected to surge at a CAGR of 13.4% to reach US$ 15.9 billion by 2031. This article delves into the factors driving this growth, the evolving market landscape, and the
Disinfectant Wipes Market Forecast 2020-2030 - Market Size, Drivers, Trends, And Competitors
Disinfectant Wipes Market Forecast 2020-2030 - Market Size, Drivers, Trends, And …
The COVID-19 pandemic has precipitated a remarkable surge in the demand for disinfectant products, with a notable emphasis on disinfectant wipes as an essential tool in maintaining hygiene and preventing the spread of pathogens. This research report delves into the multifaceted landscape of the disinfectant wipes market, elucidating key trends, drivers, and innovations shaping the industry. 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐫𝐞𝐩𝐨𝐫𝐭 @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=70359 Key Players and Market Developments Key players
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Study
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Stud …
The global 𝐭𝐢𝐬𝐬𝐮𝐞 𝐛𝐚𝐧𝐤𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 reached a value of US$ 1,056.4 million in 2017 and is projected to nearly triple to US$ 2,903.3 million by 2026, with a robust Compound Annual Growth Rate (CAGR) of approximately 12.0% from 2018 to 2026. Factors such as increasing awareness about tissue donation, technological advancements, and a growing target patient population are anticipated to propel market growth during this period. Moreover, the market is expected
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
This report by Transparency Market Research, Inc. assesses the present state and future growth potential of the global 𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐜𝐥𝐨𝐬𝐮𝐫𝐞 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭. It features a comprehensive executive summary, offering insights into various segments of the market. Additionally, the report provides detailed analysis and data on product, access type, application, end user, and regional segments within the global market. Vascular closure devices is estimated to reach a value of ~US$ 1 Bn

All 5 Releases


More Releases for Asparaginase

Asparaginase Market Significantly Stepping towards the Success Till 2027|
Asparaginase is an enzyme that is used in both medicine and food production. L-asparaginase is a medication used to treat acute lymphoblastic leukemia (ALL). It is administered via injection into a vein, muscle, or beneath the skin. In 2020, the global Asparaginase market size was US$ 359 million and it is expected to reach US$ 399.2 million by the end of 2027, with a CAGR of 1.5% during 2021-2027. Request Sample
L-Asparaginase Market Size, Share, Development by 2024
Global Info Research offers a latest published report on L-Asparaginase Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 102 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. Click to view the full report TOC, figure and tables: https://www.globalinforesearch.com/global-l-asparaginase-market_p130165.html   Scope of the Report: The worldwide market for L-Asparaginase is
Global Asparaginase Market
The “Global Asparaginase Market” is an in depth study analyzing the current state and forecast 2018-2025. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Global Asparaginase Market provides analysis of market covering the industry trends, recent developments in the market and competitive landscape. Competitive analysis includes competitive information of leading players in market, their company profiles, product
Medical Asparaginase Market-entry and expansion strategies
MarketResearchReports.Biz adds “Global Medical Asparaginase Market Share, Size, Trends and Forecast Market Research Report” reports to its database. This report provides a strategic analysis of the Medical Asparaginase and the growth estimates for the forecasted period. Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin's lymphoma. It is given by injection into a vein, muscle, or under the
Global Medical Asparaginase Sales Market Report 2018
The Global Medical Asparaginase Sales Market Report 2018 is a professional and in-depth study on the current state of the Medical Asparaginase industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Medical Asparaginase Industry analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status. Secondly, development policies and plans are discussed as well as manufacturing processes and cost structures. This
Global Asparaginase Market Research Report 2017
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Asparaginase in these regions, from 2012 to 2022 (forecast), covering North America Europe China Japan Southeast Asia India Global Asparaginase market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including Kyowa Hakko Kirin Alize Pharma Jinan Welcome Biochemical Pharmaceutical Guangzhou Baiyuan Shanmingxing Pharmaceutical United Biotech GIHI Chemicals Changzhou Qianhong Bio-pharma Liaoyuan Dikang ZHPHARMA Taj Pharmaceuticals Porton Biopharma On